IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:1886-1894.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-0635

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrington, L. M.
Right arrow Articles by Boulton, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrington, L. M.
Right arrow Articles by Boulton, M.

Differential Regulation of Key Stages in Early Corneal Wound Healing by TGF-ß Isoforms and Their Inhibitors

Louise M. Carrington,1,2 Julie Albon,1,2 Ian Anderson,3 Christina Kamma,1,2 and Mike Boulton1,2

1From the Cell and Molecular Unit, School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; the 2Cardiff Institute of Tissue Engineering and Repair, Cardiff University, Cardiff, United Kingdom; and 3Cambridge Antibody Technology, Cambridge, United Kingdom.

PURPOSE. Inhibition of TGF-ß reduces myofibroblast differentiation and fibrosis in the cornea. Determining the actions of distinct TGF-ß isoforms and their inhibitors during early corneal wound healing is an essential step in guiding therapeutic intervention.

METHODS. Bovine serum-free corneal cell and wounded organ cultures were challenged with a range of concentrations of TGF-ß1, 2, and -ß3; IL-10; and neutralizing human monoclonal antibodies (mAbs) against TGF-ß1 (CAT-192) or -ß2, (CAT-152). Cultures were assessed for re-epithelialization, proliferation (cell counts and cresyl violet assay), morphology (histologic examination), repopulation of the area under the wound, and myofibroblast transformation ({alpha}-smooth muscle actin) between 0 and 5 days.

RESULTS. TGF-ß1 delayed re-epithelialization, increased repopulation of the stroma, increased keratocyte proliferation and was the only isoform to promote myofibroblast differentiation. The anti-TGF-ß1 mAb, CAT-192 promoted re-epithelialization and reduced repopulation of the stroma. Exogenous TGF-ß3 had little effect on re-epithelialization but reduced repopulation of the stroma. IL-10 promoted corneal re-epithelialization at low doses but inhibited this response at high doses. Stromal repopulation was prevented by all doses of IL-10. TGF-ß2 or the anti-TGF-ß2 mAb, CAT-152 had little effect on any repair parameter.

CONCLUSIONS. The results confirm TGF-ß1 as the principal isoform in corneal wound healing and suggest that inhibition of the action of TGF-ß1 can promote corneal wound healing. Treatment with the anti-TGF-ß1 mAb CAT-192 accelerates corneal re-epithelialization but reduces cell repopulation of the stroma. The cytokines TGF-ß3 and IL-10 have opposing actions to that of TGF-ß1.





This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
A. M. Bernstein, S. S. Twining, D. J. Warejcka, E. Tall, and S. K. Masur
Urokinase Receptor Cleavage: A Crucial Step in Fibroblast-to-Myofibroblast Differentiation
Mol. Biol. Cell, July 1, 2007; 18(7): 2716 - 2727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology